It's All in Your Head

Update Item Information
Identifier walsh_2013_s2_c3
Title It's All in Your Head
Creator William L. Hills; Marjorie R. Grafe; Jane Weissman; Julie Falardeau; Michele K. Mass; William T. Shults
Affiliation (WLH) (JF) Oregon Health & Science University/Casey Eye Institute, Portland, OR; (WLH) (MKM) Oregon Health & Science University/Neurology, Portland, OR; (MRG) Oregon Health & Science University/Pathology, Portland, OR; (JW) Oregon Health & Science University/Radiology, Portland, OR; (WTS) Legacy Good Samaritan Hospital/Dever's Eye Institute, Portland, OR
Subject Erdheim-Chester Disease; Histiocytosis; Non-Langerhans Cell; Intracranial; Visual Fields; Migraine Visual Aura
Description Resection of superficial lesion was performed on 11/29/11. Immunohistochemical examination found lipid laden histiocytes equivocal for S100, positive for CD68 and CD163 arranged in sheets of inflammation with collagen deposition. The large histiocytic cells were CD1a negative and Factor XIIIa positive. Touton giant cells were identified without evidence of emperipolesis. Microbial DNA PCR was negative. No acid fast bacilli, mycobacterium tuberculosis complex or Mycobacterium avium complex DNA were detected. There were no non-caseating sarcoidal granulomas. Pathology consultation from UCSF felt the histiocyte population was S-100 positive, however, NIH/NCI did not. Nonetheless, both agreed that pathology was consistent with Erdheim-Chester disease (ECD). Search for extra-cranial involvement included CT of chest and abdomen, trans-thoracic echocardiogram, long bone x-rays and whole body PET scan, which were unremarkable. Surveillance MRI January and May 2012 found decreasing size of enhancing intracranial lesions without treatment. Repeat visual fields have remained stable and neurologic examination found improved left lower extremity strength. ECD is a non-Langerhans cell histiocytosis (NLCH) proliferative disorder characterized by infiltration of various tissues by foamy histiocytes surrounded by fibrosis of unknown etiology. 1,2 There is a strong male predominance and a mean age at diagnosis of 55 yrs. 1 Osteosclerosis of the long bones with pain is common. Other organs involved are skin, lungs, heart, and kidneys. Retroperitoneal and orbital lesions reported. 2 Central nervous system (CNS) involvement can be seen in up to 50% of affected patients.1 Immunohistochemistry is necessary to differentiate from other NLCH. Presentation typically consists of cerebellar and pyramidal syndromes. 2 CNS MR imaging has revealed intra and extra-axial lesions, including ependymal enhancement, brainstem lesions, thickening of the pituitary stalk, cavernous sinus, sellar and hypothalamic lesions. 3 Treatment is controversial and has included high dose interferon alpha, steroids, biphosphonates, and cytotoxic agents with variable results. 4 Isolated intracranial ECD has been reported twice previously.
History Migraine headache with visual aura since age 27 and upper airway resistance syndrome.
Pathology Pathology was consistent with Erdheim-Chester disease (ECD).
Disease/Diagnosis Isolated intracranial Erdheim-Chester disease presenting as an atypical migraine visual aura without headache
Clinical Brain MRI revealed revealed multiple intra- and extra-axial enhancing masses including brain parenchyma, pituitary infundibulum and corpus callosum; Visual Acuity 20/20 right eye, 20/30 left eye; Color vision 10/10 right, 7/10 left without RAPD
Presenting Symptom A 45-year-old woman with a history of migraine headaches with visual aura presented after an atypical visual aura of 3 days duration without headache.
Neuroimaging CT Scan; MRI; Flow Cytometry
Treatment High dose interferon alpha, steroids, biphosphonates, and cytotoxic agents.
Date 2013-02
References 1. Haroche J, Arnaud L, Amoura Z. Erdheim-Chester disease. Curr Opin Rheumatol, 24, 53-59, 2012. 2. Conley A, Manjila S, Guan H, et al. Non-Langerhans cell histiocytosis with isolated CNS involvement: An unusual variant of Erdheim-Chester disease. Neuropathology, 30, 634-637, 2010. 3. Sedrack P, Ketonen L, Hou P, et al. Erdheim-Chester Disease of the Central Nervous System: New Manifestations of a Rare Disease. Am J Neuroradiol, 32, 2126-31, 2011. 4. Hervier B, Arnaud L, Charlotte F, et al. Treatment of Erdheim-Chester Disease with Long-Term High Dose Interferon-alpha. Semin Arthritis Rheum, Jun, 41(6), 907-13, 2012. 5. Rushing EJ, Bouffard JP, Neal CJ, et al. Erdheim-Chester Disease mimicking a primary brain tumor: Case report. J Neurosurg, 100, 1115-1118, 2004.
Language eng
Format application/pdf
Type Text
Source 45th Annual Frank Walsh Society Meeting
Relation is Part of NANOS Annual Meeting 2013
Collection Neuro-Ophthalmology Virtual Education Library: Walsh Session Annual Meeting Archives: https://novel.utah.edu/Walsh/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2013. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6x66jhk
Setname ehsl_novel_fbw
ID 179144
Reference URL https://collections.lib.utah.edu/ark:/87278/s6x66jhk
Back to Search Results